161 related articles for article (PubMed ID: 29417469)
1. Association between systemic leptin and neurotensin concentration in adult individuals with and without type 2 diabetes mellitus.
Barchetta I; Ciccarelli G; Cimini FA; Ceccarelli V; Orho-Melander M; Melander O; Cavallo MG
J Endocrinol Invest; 2018 Oct; 41(10):1159-1163. PubMed ID: 29417469
[TBL] [Abstract][Full Text] [Related]
2. Increased Plasma Proneurotensin Levels Identify NAFLD in Adults With and Without Type 2 Diabetes.
Barchetta I; Cimini FA; Leonetti F; Capoccia D; Di Cristofano C; Silecchia G; Orho-Melander M; Melander O; Cavallo MG
J Clin Endocrinol Metab; 2018 Jun; 103(6):2253-2260. PubMed ID: 29590379
[TBL] [Abstract][Full Text] [Related]
3. Impaired bone matrix glycoprotein pattern is associated with increased cardio-metabolic risk profile in patients with type 2 diabetes mellitus.
Barchetta I; Ceccarelli V; Cimini FA; Bertoccini L; Fraioli A; Alessandri C; Lenzi A; Baroni MG; Cavallo MG
J Endocrinol Invest; 2019 May; 42(5):513-520. PubMed ID: 30132286
[TBL] [Abstract][Full Text] [Related]
4. Neurotensin Is a Lipid-Induced Gastrointestinal Peptide Associated with Visceral Adipose Tissue Inflammation in Obesity.
Barchetta I; Cimini FA; Capoccia D; Bertoccini L; Ceccarelli V; Chiappetta C; Leonetti F; Di Cristofano C; Silecchia G; Orho-Melander M; Melander O; Cavallo MG
Nutrients; 2018 Apr; 10(4):. PubMed ID: 29690638
[TBL] [Abstract][Full Text] [Related]
5. High pro-neurotensin levels in individuals with type 1 diabetes associate with the development of cardiovascular risk factors at follow-up.
Cimini FA; Barchetta I; Bertoccini L; Ceccarelli V; Baroni MG; Melander O; Cavallo MG
Acta Diabetol; 2022 Jan; 59(1):49-56. PubMed ID: 34455471
[TBL] [Abstract][Full Text] [Related]
6. Circulating Pro-Neurotensin in gestational diabetes mellitus.
Tönjes A; Kralisch S; Hoffmann A; Schleinitz D; Kratzsch J; Blüher M; Stumvoll M; Kovacs P; Fasshauer M; Ebert T
Nutr Metab Cardiovasc Dis; 2019 Jan; 29(1):23-29. PubMed ID: 30527352
[TBL] [Abstract][Full Text] [Related]
7. Circulating pro-neurotensin levels predict bodyweight gain and metabolic alterations in children.
Barchetta I; Bertoccini L; Sentinelli F; Bailetti D; Marini G; Cimini FA; Ceccarelli V; Struck J; Schulte J; Loche S; Cossu E; Melander O; Cavallo MG; Baroni MG
Nutr Metab Cardiovasc Dis; 2021 Mar; 31(3):902-910. PubMed ID: 33549442
[TBL] [Abstract][Full Text] [Related]
8. Greater circulating DPP4 activity is associated with impaired flow-mediated dilatation in adults with type 2 diabetes mellitus.
Barchetta I; Ciccarelli G; Barone E; Cimini FA; Ceccarelli V; Bertoccini L; Sentinelli F; Tramutola A; Del Ben M; Angelico F; Baroni MG; Lenzi A; Cavallo MG
Nutr Metab Cardiovasc Dis; 2019 Oct; 29(10):1087-1094. PubMed ID: 31431395
[TBL] [Abstract][Full Text] [Related]
9. Effect of gastric bypass and gastric banding on proneurotensin levels in morbidly obese patients.
Christ-Crain M; Stoeckli R; Ernst A; Morgenthaler NG; Bilz S; Korbonits M; Struck J; Bergmann A; Müller B; Keller U
J Clin Endocrinol Metab; 2006 Sep; 91(9):3544-7. PubMed ID: 16787986
[TBL] [Abstract][Full Text] [Related]
10. Pro-Neurotensin/Neuromedin N and Risk of Incident Metabolic Syndrome and Diabetes Mellitus in the REGARDS Cohort.
Nicoli CD; Carson AP; Plante TB; Leann Long D; McClure LA; Schulte J; Cushman M
J Clin Endocrinol Metab; 2021 Aug; 106(9):e3483-e3494. PubMed ID: 34013344
[TBL] [Abstract][Full Text] [Related]
11. Plasma Leptin in Patients at Intermediate to High Cardiovascular Risk With and Without Type 2 Diabetes Mellitus.
Montagnana M; Fava C; Targher G; Franchini M; Danese E; Bonafini S; De Cata A; Salvagno GL; Ruzzenente O; Guidi GC; Lippi G
J Clin Lab Anal; 2017 Mar; 31(2):. PubMed ID: 27470535
[TBL] [Abstract][Full Text] [Related]
12. Identification of U-shaped curve relation between proneurotensin and risk of coronary artery disease (CAD) in patients with premature CAD.
Wang LJ; Liu MJ; Zhai TS; Zhu HJ; Gong FY; Yang HB; Yan KM; Pan H; Zeng Y
Nutr Metab Cardiovasc Dis; 2020 Mar; 30(3):483-491. PubMed ID: 31926821
[TBL] [Abstract][Full Text] [Related]
13. Irisin and leptin concentrations in relation to obesity, and developing type 2 diabetes: A cross sectional and a prospective case-control study nested in the Normative Aging Study.
Sahin-Efe A; Upadhyay J; Ko BJ; Dincer F; Park KH; Migdal A; Vokonas P; Mantzoros C
Metabolism; 2018 Feb; 79():24-32. PubMed ID: 29108900
[TBL] [Abstract][Full Text] [Related]
14. Relation between plasma leptin and anthropometric and metabolic covariates in lean and obese diabetic and hyperlipidaemic Asian Northern Indian subjects.
Misra A; Arora N; Mondal S; Pandey RM; Jailkhani B; Peshin S; Chaudhary D; Saluja T; Singh P; Chandna S; Luthra K; Vikram NK
Diabetes Nutr Metab; 2001 Feb; 14(1):18-26. PubMed ID: 11345162
[TBL] [Abstract][Full Text] [Related]
15. Adiponectin, insulin resistance and clinical expression of the metabolic syndrome in patients with Type 2 diabetes.
Mojiminiyi OA; Abdella NA; Al Arouj M; Ben Nakhi A
Int J Obes (Lond); 2007 Feb; 31(2):213-20. PubMed ID: 16755284
[TBL] [Abstract][Full Text] [Related]
16. Gender-specific leptinemia and its relationship with some components of the metabolic syndrome in Moroccans.
Lyoussi B; Ragala MA; Mguil M; Chraibi A; Israili ZH
Clin Exp Hypertens; 2005 May; 27(4):377-94. PubMed ID: 15921074
[TBL] [Abstract][Full Text] [Related]
17. Proneurotensin Predicts Cardiovascular Disease in an Elderly Population.
Fawad A; Bergmann A; Struck J; Nilsson PM; Orho-Melander M; Melander O
J Clin Endocrinol Metab; 2018 May; 103(5):1940-1947. PubMed ID: 29546332
[TBL] [Abstract][Full Text] [Related]
18. Association of serum Sestrin2 level with metabolic risk factors in newly diagnosed drug-naïve type 2 diabetes.
Chung HS; Hwang HJ; Hwang SY; Kim NH; Seo JA; Kim SG; Kim NH; Baik SH; Choi KM; Yoo HJ
Diabetes Res Clin Pract; 2018 Oct; 144():34-41. PubMed ID: 30099048
[TBL] [Abstract][Full Text] [Related]
19. Affinity kinetics of leptin-reactive immunoglobulins are associated with plasma leptin and markers of obesity and diabetes.
Bouhajja H; Bougacha-Elleuch N; Lucas N; Legrand R; Marrakchi R; Kaveri SV; Jamoussi K; Ayadi H; Abid M; Mnif-Feki M; Fetissov SO
Nutr Diabetes; 2018 May; 8(1):32. PubMed ID: 29795184
[TBL] [Abstract][Full Text] [Related]
20. Plasma leptin level is associated with cardiac autonomic dysfunction in patients with type 2 diabetes: HSCAA study.
Kurajoh M; Koyama H; Kadoya M; Naka M; Miyoshi A; Kanzaki A; Kakutani-Hatayama M; Okazaki H; Shoji T; Moriwaki Y; Yamamoto T; Emoto M; Inaba M; Namba M
Cardiovasc Diabetol; 2015 Sep; 14():117. PubMed ID: 26338087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
